Entero Therapeutics Announces Proposed Reverse Merger with Journey Therapeutics, A Clinical Stage, First-in-Class, Next-Generation ADC-rivalling Nano-immunoconjugates Biopharmaceutical Company

Stock Information for Entero Therapeutics Inc.

Loading

Please wait while we load your information from QuoteMedia.